HIGH-VOLUME · HOSP-HEAVY
lacosamide Side Effects
lacosamide (also sold as Vimpat) is HIGH-VOLUME in this FAERS book #173 of 524 by FAERS report count. Signature opener: HOSP-HEAVY - 34.0% mention hospitalization (12,020 reports).
Data updated 2026-05-15
- 35,350
- FAERS reports
FAERS voluntary reports, 2007 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
lacosamide: 34.0% mention hospitalization (12,020 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #173 of 524 by FAERS report count.
High-report extract for lacosamide (Vimpat): 35,350 FAERS rows (2007-2025). Top named reactions: SEIZURE, DIZZINESS, SOMNOLENCE. Outcome stamps DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2007–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
SEIZURE leads 6,507 of 35,350 reports
Who reports · age peak 18-44 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 18-44 (7,367 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (3,025 reports, 8.6%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 1,046 |
| SEIZURE | 253 |
| TOXICITY TO VARIOUS AGENTS | 177 |
| CARDIAC ARREST | 172 |
| STATUS EPILEPTICUS | 170 |
| COMPLETED SUICIDE | 150 |
| PNEUMONIA | 122 |
| CARDIO-RESPIRATORY ARREST | 109 |
| SUDDEN UNEXPLAINED DEATH IN EPILEPSY | 101 |
| MULTIPLE-DRUG RESISTANCE | 84 |
| OVERDOSE | 82 |
| DRUG INEFFECTIVE FOR UNAPPROVED INDICATION | 81 |
| EPILEPSY | 81 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 77 |
| SEPSIS | 77 |
| METABOLIC ACIDOSIS | 75 |
| FALL | 73 |
| PNEUMONIA ASPIRATION | 73 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (12,020, 34.0% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| SEIZURE | 2,541 |
| STATUS EPILEPTICUS | 728 |
| FALL | 713 |
| EPILEPSY | 519 |
| HOSPITALISATION | 497 |
| OVERDOSE | 497 |
| SOMNOLENCE | 481 |
| DRUG INTERACTION | 466 |
| PNEUMONIA | 457 |
| VOMITING | 453 |
| DIZZINESS | 440 |
| GENERALISED TONIC-CLONIC SEIZURE | 420 |
| FATIGUE | 405 |
| CONVULSION | 393 |
| PYREXIA | 367 |
| TOXICITY TO VARIOUS AGENTS | 351 |
| HEADACHE | 342 |
| NAUSEA | 325 |
How to read lacosamide FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 35,350 voluntary reports linked to lacosamide (Vimpat), 2007-2025. Death is listed on 3,025 (8.6%). Hospitalization appears on 12,020 (34.0%). Top co-reported indication: Product Used For Unknown Indication.
CASELOAD books overweight common drugs and loud reporting cultures; HOSP-HEAVY is the page opener, not a per-patient risk.
Read with lacosamide
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 35,161 FAERS cases (Δ 189 lighter vs lacosamide); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 35,138 FAERS cases (Δ 212 lighter vs lacosamide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 35,897 FAERS cases (Δ 547 heavier vs lacosamide); DEATH-MARKED · HOSP-LIGHT · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 36,174 FAERS cases (Δ 824 heavier vs lacosamide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 53.6 pp vs lacosamide's DEATH-HEAVY): CASELOAD · HOSP-MID.
lacosamide stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.